These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 25874971

  • 1. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y, Yuan A, Chuchuen O, Ham A, Yang KH, Katz DF.
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [Abstract] [Full Text] [Related]

  • 2. Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel.
    Gao Y, Katz DF.
    PLoS One; 2013 Jun; 8(9):e74404. PubMed ID: 24040241
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Design of tenofovir-UC781 combination microbicide vaginal gels.
    Kiser PF, Mahalingam A, Fabian J, Smith E, Damian FR, Peters JJ, Katz DF, Elgendy H, Clark MR, Friend DR.
    J Pharm Sci; 2012 May; 101(5):1852-64. PubMed ID: 22359356
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A, Devlin B, Cost M, Rohan LC.
    Mol Pharm; 2014 May 05; 11(5):1533-41. PubMed ID: 24693866
    [Abstract] [Full Text] [Related]

  • 10. Sensitivity Analysis of a Pharmacokinetic Model of Vaginal Anti-HIV Microbicide Drug Delivery.
    Jarrett AM, Gao Y, Hussaini MY, Cogan NG, Katz DF.
    J Pharm Sci; 2016 May 05; 105(5):1772-1778. PubMed ID: 27012224
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR, Friend DR.
    AIDS Res Hum Retroviruses; 2012 Nov 05; 28(11):1458-66. PubMed ID: 22394281
    [Abstract] [Full Text] [Related]

  • 12. Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
    Adams JL, Kashuba AD.
    Best Pract Res Clin Obstet Gynaecol; 2012 Aug 05; 26(4):451-62. PubMed ID: 22306523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK, Morrow KM, Carballo-Diéguez A, Mantell JE, Hoffman S, Gai F, Maslankowski L, El-Sadr WM, Mayer KH.
    J Womens Health (Larchmt); 2008 Apr 05; 17(3):383-92. PubMed ID: 18328009
    [Abstract] [Full Text] [Related]

  • 16. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
    Johnson TJ, Clark MR, Albright TH, Nebeker JS, Tuitupou AL, Clark JT, Fabian J, McCabe RT, Chandra N, Doncel GF, Friend DR, Kiser PF.
    Antimicrob Agents Chemother; 2012 Dec 05; 56(12):6272-83. PubMed ID: 23006751
    [Abstract] [Full Text] [Related]

  • 17. Covert use, vaginal lubrication, and sexual pleasure: a qualitative study of urban U.S. Women in a vaginal microbicide clinical trial.
    Hoffman S, Morrow KM, Mantell JE, Rosen RK, Carballo-Diéguez A, Gai F.
    Arch Sex Behav; 2010 Jun 05; 39(3):748-60. PubMed ID: 19636696
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics and Pharmacodynamics of Tenofovir Reduced-Glycerin 1% Gel in the Rectal and Vaginal Compartments in Women: A Cross-Compartmental Study With Directly Observed Dosing.
    Justman JE, Nair GL, Hendrix CW, Piper JM, Marzinke MA, Dai JY, Pan Z, Galaska B, Levy L, Schwartz JL, Balar B, Kunjara Na Ayudhya RP, Mushamiri I, McGowan I, Dezzutti CS, MTN-014 Study Team.
    J Acquir Immune Defic Syndr; 2018 Jun 01; 78(2):175-182. PubMed ID: 29767639
    [Abstract] [Full Text] [Related]

  • 19. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS, Ugaonkar SR, Shi L, Buckheit KW, Lakougna H, Nagaraja U, Gwozdz G, Goldman L, Kiser PF, Buckheit RW.
    J Pharm Sci; 2012 Apr 01; 101(4):1423-35. PubMed ID: 22227864
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetic modeling of a gel-delivered dapivirine microbicide in humans.
    Halwes ME, Steinbach-Rankins JM, Frieboes HB.
    Eur J Pharm Sci; 2016 Oct 10; 93():410-8. PubMed ID: 27559026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.